Edited by John B. Saunders, Professor and Consultant Physician in Internal Medicine and Addiction Medicine, University of Queensland, University of Sydney, St. John of God Health Care, Wesley Health Care, and South Pacific Private Hospital, Sydney, Australia, Katherine M. Conigrave, Professor in Addiction Medicine and Public Health, Sydney Medical School, University of Sydney, and Royal Prince Alfred Hospital and Concord Hospitals, Sydney, Australia, Noeline C. Latt, Addiction Medicine Specialist, Royal North Shore Hospital and Sydney Medical School, University of Sydney, Australia, David J. Nutt, Professor of Psychopharmacology, Division of Brain Science, Dept of Medicine, Hammersmith Hospital, Imperial College London, UK, E. Jane Marshall, Consultant Psychiatrist, Alcohol Studies, South London and Maudsley National Health Service Trust and the National Addiction Centre, Institute of Psychiatry, King's College London, UK, Walter Ling, Professor of Psychiatry, Integrated Substance Abuse Program (ISAP), School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, CA, USA, and Susumu Higuchi, Director, National Hospital Organization Kurihama Medical and Addiction Center, Kanagawa, Japan
Professor John B. Saunders is a Professor and Consultant Physician in Internal Medicine and Addiction Medicine, with appointments at the University of Queensland and University of Sydney, and with several private hospital groups. He graduated in pharmacology and then medicine from the University of Cambridge, and undertook specialist medical training in internal medicine, gastroenterology and addiction medicine. His career as a clinician, service director, researcher and academic in addictive disorders extends back over 40 years. He has been a member of many Australian government committees, including the Australian National Council on Drugs (2001-07). He has worked with the World Health Organization since 1981 and was responsible for developing the AUDIT Questionnaire. He is a member of WHO's Expert Advisory Panel on Substance Abuse and the ICD 11 Substance-Related and Addictive Disorders Workgroup. He has published four books and over 330 scientific papers, reviews and chapters.
Professor Katherine M. Conigrave is Senior Staff Specialist in Addiction Medicine and Public Health at Royal Prince Alfred Hospital and Concord Hospital in Sydney, Australia. She has been involved for many years in training medical and other health professionals through Sydney Medical School, University of Sydney, and through training sessions for practising health professionals. Professor Conigrave's research has a focus on detection and early intervention for alcohol problems, and on improving implementation of evidence-based practice in prevention and treatment of substance use disorders. She has over 100 academic publications, has received the Senior Scientist Award for the Australasian Professional Society for Alcohol and Other Drugs, and has acted as short-term consultant to the World Health Organization on alcohol screening and brief intervention.
Dr Noeline C. Latt is a Senior Staff Specialist in Addiction Medicine at Royal North Shore Hospital, Clinical Lecturer at the University of Sydney, and a Foundation Fellow of the Chapter of Addiction Medicine, Royal Australasian College of Physicians. She is a Physician and Addiction Medicine Specialist with extensive experience in clinical pharmacology and internal medicine at St Thomas' Hospital, the Royal Free Hospital and Royal Northern Hospitals in London and St Vincent's Hospital in Sydney. After a period as Medical Director in the Pharmaceutical Industry, she returned to clinical medicine over twenty years ago and commenced training in Addiction Medicine at Westmead Hospital and Royal Prince Alfred Hospital. As Director of the Ryde and Hornsby Drug & Alcohol Service she developed a drug and alcohol unit offering consultation liaison services and teaching programs in alcohol and substance use disorders.
Professor David J. Nutt is Consultant Psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Hammersmith Hospital, Imperial College London. Here he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders and to search for new treatments. He has published over 400 original research papers, a similar number of reviews and book chapters, eight government reports on drugs and 28 books, including one for the general public, "Drugs: without the hot air", that won the Transmission Prize in 2014. He is currently the President of the European Brain Council and Founding Chair of DrugScience (formerly the Independent Scientific Committee on Drugs (ISCD). Previously he has been president of the British Association of Psychopharmacology. the British Neuroscience Association and the European College of Neuropsychopharmacology.
Dr E. Jane Marshall is a Consultant Psychiatrist in Alcohol Studies at the South London and Maudsley NHS Foundation Trust and Senior Lecturer in the Addictions at the National Addiction Centre, Institute of Psychiatry, King's College London. She trained in Psychiatry at St Patrick's Hospital, Dublin, and St Bartholomew's and the Maudsley Hospitals in London. Her clinical work is currently focused on a specialist out-patient and in-patient alcohol service, and also a service for addicted healthcare professionals. She is lead clinician for the MSc program in Addiction at the Institute of Psychiatry. Research interests include the evaluation of treatment for alcohol problems in specialist and generalist settings and, in particular, treatment for addicted healthcare professionals.
Professor Walter Ling is Professor of Psychiatry and the Founding Director of the Integrated Substance Abuse Programs (ISAP) at UCLA, one of the foremost substance abuse research groups in the US. He is board certified in neurology and psychiatry, is active in research and clinical work, and has been listed in 'Best Doctors in America'. Dr Ling's research in opiate pharmacotherapy provided pivotal information for the approval of buprenorphine and naltrexone. His current focus of research includes abuse and dependence on methamphetamine, cocaine, heroin and prescription opiates; opiate induced hyperalgesia, treatment of pain in opiate-maintained patients, including those treated with buprenorphine and the role of buprenorphine in the management of pain in these patients. Dr Ling is a fellow of the American Academy of Neurology; he has served as Commissioner for the Narcotics and Dangerous Drugs Commission, and is a consultant on narcotics for the World Health Organization.
Professor Susumu Higuchi is Director of the National Hospital Organization Kurihama Medical and Addiction Center and Director of the World Health Organization (WHO) Collaborating Centre on Research and Training of Alcohol-Related Problems in Yokosuka, Tokyo, Japan. He has principally worked on genetics and clinical studies of alcohol use disorders, especially on the implications of genetic variations of alcohol-metabolising enzymes on pharmacokinetic and pharmacodynamic effects, organ damage and alcohol-use disorders. He has published more than 220 scientific papers in well-recognised international journals, and more than 400 papers in domestic journals. He is President of the International Society for Biomedical Research on Alcoholism (ISBRA), congress president in 2014, a director of the International Society of Addiction Medicine, and president of the Japanese Society of Alcohol-Related Problems.
Professor Peter Anderson, Substance Use Policy and Practice, Institute of Health and Society, Newcastle University, UK
Associate Professor Sawitri Assanangkornchai, Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Thailand
Associate Professor Tatiana Balachova, University of Oklahoma Health Sciences Center, Department of Pediatrics and the Center on Child Abuse and Neglect, University of Oklahoma, USA
Professor Robert Batey, University of Sydney and Flinders University, South Australia; Department of Medicine, Alice Springs Hospital, Australia
Dr Jenny Bearn, Maudsley Hospital, South London and Maudsley NHS Foundation Trust, UK
Dr James Bell, Addictions Clinical Academic Group, Kings Health Partners, London, UK
Associate Professor Renee Bittoun, Sydney Medical School, Faculty of Medicine, University of Sydney; Director, Smoking Cessation Unit, and Smokers Clinics, Brain and Mind Research Institute, Camperdown, Australia
Associate Professor Yvonne Bonomo, St Vincent's Hospital Melbourne, and Departments of Medicine and Paediatrics, University of Melbourne, Australia
Dr Henrietta Bowden-Jones, National Problem Gambling Clinic, London, UK; Central North West London NHS Foundation Trust, UK
Dr Jonathan Brett, University of Sydney; Drug Health, Royal Prince Alfred Hospital, Sydney, Australia
Dr Adam Brodie, NHS Lanarkshire, Coathill House, UK
Professor Katherine M. Conigrave, Sydney Medical School, University of Sydney, and Royal Prince Alfred Hospital and Concord Hospitals, Sydney, Australia
Associate Professor Jason P. Connor, Centre for Youth Substance Abuse, The University of Queensland, Royal Brisbane and Women's Hospital, Australia
Professor Ilana B. Crome, Keele University, UK; South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Staffordshire, UK; Queen Mary University, London, UK; Imperial College London, UK
Professor H. Valerie Curran, Brain Sciences, University College London, UK
Professor Louisa Degenhardt, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
Associate Professor Glenys Dore, Northern Sydney Drug & Alcohol Service, University of Sydney, Sydney Medical School, Australia; Herbert Street Clinic, Royal North Shore Hospital, Sydney, Australia
Professor Colin Drummond, Addictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, South London and Maudsley NHS Foundation Trust, UK
Associate Professor Gerald F. X. Feeney, Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Australia
Dr Emily Finch, Addictions Psychiatry, South London and Maudsley NHS Foundation Trust, Addictions Clinical Academic Group, London, UK
Mr Bradley Freeburn, Drug and Alcohol and Mental Health Unit, Aboriginal Medical Service, Redfern, Australia
Dr Sanju George, Birmingham and Solihull Mental Health NHS Foundation Trust, Solihull Integrated Addiction Services, Birmingham, UK
Professor Paul Haber, Drug Health Services, Sydney Local Health District; Discipline of Addiction Medicine, Sydney Medical School, University of Sydney, Camperdown, Australia
Professor Wayne Hall, University of Queensland Centre for Youth Substance Abuse Research and the University of Queensland Centre Clinical Research, University of Queensland, Brisbane, Australia; and National Addiction Centre, King's College London, UK
Professor Margaret Haney, Columbia University Medical Center, New York State Psychiatric Institute, New York, USA
Associate Professor Takayuki Harada, Department of Psychology, Faculty of Human Sciences, Mejiro University, Tokyo, Japan
Professor Susumu Higuchi, National Hospital Organization Kurihama Medical and Addiction Center and director of the World Health Organization (WHO) Collaborating Centre on Research and Training of Alcohol-Related Problems, Kanagawa, Japan
Dr Ralph Hingson, Division of Epidemiology and Prevention Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, USA
Professor Kazutaka Ikeda, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Dr Marianne Jauncey, Sydney Medically Supervised Injecting Centre, NSW, Australia
Associate Professor Stephen Jurd, Discipline of Psychological Medicine, Sydney Medical School, University of Sydney, and Director of Training in Psychiatry, Macquarie Hospital, North Ryde, Australia
Ms Shivani Khan, Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, USA
Dr Yasunobu Komoto, National Hospital Organization, Kurihama Medical and Addiction Center, Yokosuka City, Japan
Dr Noeline C. Latt, Royal North Shore Hospital and Sydney Medical School, University of Sydney, Australia
Professor Michael Levy, Medical School, College of Medicine Biology and Environment, Australian National University, Acton, Australia
Ms Corinne Lim, Fairfax Media Limited, Australia
Professor Walter Ling, Integrated Substance Abuse Program (ISAP), School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, USA
Professor Anne Lingford-Hughes, Centre for Neuropsychopharmacology, Division of Brain Sciences, Dept of Medicine, Imperial College London, UK
Dr E. Jane Marshall, South London and Maudsley National Health Service Trust and the National Addiction Centre, Institute of Psychiatry, King's College London, UK
Professor Ross McCormick, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Ms Satoko Mihara, Department of Clinical Psychology, National Hospital Organization Kurihama Medical and Addiction Center, Kanagawa, Japan
Professor Hisatsugu Miyata, Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan
Dr Hideki Nakayama, National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan
Dr Tim Neumann, Department of Anaesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Germany
Dr. Daisuke Nishizawa, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Professor David J. Nutt, Division of Brain Science, Dept of Medicine, Hammersmith Hospital, Imperial College London, UK
Dr Sally Porter, Turning Point Substance Misuse Services, Croydon, UK
Professor Richard Saitz, Department of Community Health Sciences, Boston University Schools of Public Health and Medicine, Boston, USA
Dr Hiroshi Sakuma, National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan
Dr Taku Sato, National Hospital Organization Kurihama Medical and Addiction Center, and Treatment of Pathological Gambling and Research Section, Kanagawa, Japan
Professor John B. Saunders, University of Queensland, University of Sydney, St. John of God Health Care, Wesley Health Care, and South Pacific Private Hospital, Sydney, Australia
Professor Andrew J. Saxon, Department of Psychiatry & Behavioural Sciences; Addiction Psychiatry Residency Program, University of Washington; Center of Excellence in Substance Abuse Treatment and Education (CESATE), VA Puget Sound Health Care System, Seattle, USA
Associate Professor Janie Sheridan, School of Pharmacy and Centre for Addiction Research, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Dr Iain Smith, Kershaw Unit, Gartnavel Royal Hospital, Glasgow, UK
Professor Claudia Spies, Department of Anaesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Germany
Professor Tim Stockwell, Centre for Addictions Research of BC; Department of Psychology, University of Victoria, Canada
Professor John Strang, National Addiction Centre, Institute of Psychiatry, King's College London, UK
Dr Pierluigi Struzzo, Department of Life Sciences, University of Trieste, Italy
Assistant Professor Catherine Woodstock Striley, Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, USA
Professor David Taylor, South London and Maudsley NHS Foundation Trust, Pharmacy Department, Maudsley Hospital, London, UK
Associate Professor Peter Thompson, Rural Clinical School, Rockhampton, Australia
Dr Sue Wilson, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK
Dr Adam R. Winstock, Consultant Psychiatrist and Addiction Medicine Specialist, South London and Maudsley NHS Trust; King's College London, UK
Associate Professor Kim Wolff, King's College London, Institute of Pharmaceutical Science, London, UK
Professor George Woody, Department of Psychiatry, University of Pennsylvania and Treatment Research Institute, Philadelphia, USA
Professor Nicholas Zwar, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
